EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
| Formula | C16H14Br2N6O4S |
| Net Charge | 0 |
| Average Mass | 546.201 |
| Monoisotopic Mass | 543.91640 |
| SMILES | NS(=O)(=O)Nc1ncnc(OCCOc2ncc(Br)cn2)c1-c1ccc(Br)cc1 |
| InChI | InChI=1S/C16H14Br2N6O4S/c17-11-3-1-10(2-4-11)13-14(24-29(19,25)26)22-9-23-15(13)27-5-6-28-16-20-7-12(18)8-21-16/h1-4,7-9H,5-6H2,(H2,19,25,26)(H,22,23,24) |
| InChIKey | DKULOVKANLVDEA-UHFFFAOYSA-N |
| Roles Classification |
|---|
| Biological Roles: | xenobiotic metabolite Any metabolite produced by metabolism of a xenobiotic compound. endothelin receptor antagonist A hormone antagonist that blocks endothelin receptors. |
| Applications: | endothelin receptor antagonist A hormone antagonist that blocks endothelin receptors. renoprotective agent Any compound that is able to prevent damage to the kidneys. antihypertensive agent Any drug used in the treatment of acute or chronic vascular hypertension regardless of pharmacological mechanism. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| ACT-132577 (CHEBI:76609) has functional parent ethylene glycol (CHEBI:30742) |
| ACT-132577 (CHEBI:76609) has role antihypertensive agent (CHEBI:35674) |
| ACT-132577 (CHEBI:76609) has role drug metabolite (CHEBI:49103) |
| ACT-132577 (CHEBI:76609) has role endothelin receptor antagonist (CHEBI:51451) |
| ACT-132577 (CHEBI:76609) has role renoprotective agent (CHEBI:231911) |
| ACT-132577 (CHEBI:76609) has role xenobiotic metabolite (CHEBI:76206) |
| ACT-132577 (CHEBI:76609) is a aromatic ether (CHEBI:35618) |
| ACT-132577 (CHEBI:76609) is a organobromine compound (CHEBI:37141) |
| ACT-132577 (CHEBI:76609) is a pyrimidines (CHEBI:39447) |
| ACT-132577 (CHEBI:76609) is a sulfamides (CHEBI:51871) |
| Incoming Relation(s) |
| macitentan (CHEBI:76607) has functional parent ACT-132577 (CHEBI:76609) |
| IUPAC Name |
|---|
| N-[5-(4-bromophenyl)-6-{2-[(5-bromopyrimidin-2-yl)oxy]ethoxy}pyrimidin-4-yl]sulfuric diamide |
| Synonyms | Source |
|---|---|
| ACT-132577 | ChEMBL |
| aprocitentan | ChEMBL |
| Aprocitentan | ChEMBL |
| Macitentan metabolite m6 | ChEMBL |
| Tryvio | ChEMBL |
| Brand Name | Source |
|---|---|
| Jeraygo | ChEMBL |
| Manual Xrefs | Databases |
|---|---|
| US2008233188 | Patent |
| WO2007119214 | Patent |
| WO2008026156 | Patent |
| Registry Numbers | Sources |
|---|---|
| Reaxys:11340634 | Reaxys |
| Citations |
|---|